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1408Objective: The objective of this study was to examine the effect of arterial grafting on long-term coronary artery
bypass grafting mortality.
Methods: Consecutive coronary artery bypass grafting surgeries performed at a single tertiary care center be-
tween 1995 and 2007 were reviewed. Long-term survival was compared among patients according to the type of
arterial grafts used: no internal thoracic artery, single internal thoracic artery, single internal thoracic artery with
other arterial graft, or bilateral internal thoracic artery. Cox proportional hazard models were generated to ex-
amine the association of arterial grafting with mortality.
Results: A total of 8264 isolated coronary artery bypass grafting operations were performed and followed for
a median time of 4.7 years (interquartile range, 2.1–7.5). A single internal thoracic artery was used in the ma-
jority of patients (79%), multiple arterial grafts were used in 24% of patients, and bilateral internal thoracic
artery grafts were used in 13% of patients. Patients who received multiple arterial grafts were more likely to
be younger, to be male, and to undergo non-urgent surgery. After adjusting for these differences, patients
who received bilateral internal thoracic artery grafts were found to have a significant survival advantage
when compared with all other patients, including those who received a single internal thoracic artery plus other
arterial grafts (hazard ratio, 0.818; confidence interval, 0.672–0.996). Survival at 10 years was 71% for patients
with bilateral internal thoracic artery grafts compared with 66% for patients with single internal thoracic artery
grafts and 58% for patients with no internal thoracic artery graft. Patients with bilateral internal thoracic artery
grafts had significantly better freedom from readmission for acute coronary syndrome (hazard ratio, 0.802; con-
fidence interval, 0.668–0.963).
Conclusions: After adjusting for relevant clinical differences, only multiple arterial grafting using the bilateral
internal thoracic artery was able to offer a long-term survival advantage over single internal thoracic artery graft-
ing in patients undergoing coronary artery bypass grafting. (J Thorac Cardiovasc Surg 2012;144:1408-15)Earn CME credits at
http://cme.ctsnetjournals.org
Since its introduction approximately 4 decades ago, coro-
nary artery bypass grafting (CABG) has established itself
as an important therapeutic intervention for patients with
symptomatic coronary artery disease.1 However, despite
the established long-term results of CABG, many have ad-
vocated that revascularization with arterial grafts rather
than vein grafts offers improved outcomes after CABG.2-5
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The Journal of Thoracic and Cardiovascular Suryet to become the standard approach for the majority of
patients undergoing CABG surgery. This is best
exemplified by reports from large registries suggesting
that the use of MAG is limited to a fraction (10%) of
all patients undergoing CABG.6
Evidence suggesting a benefit fromMAG is based in part
on studies that have built on the proven success of left inter-
nal thoracic artery (LITA) grafts.2,4 As such, LITAþ right
internal thoracic artery (RITA) grafting, also referred to as
‘‘bilateral internal thoracic artery’’ (BITA) grafting, has
been suggested by some investigators to confer a long-
term survival advantagewhen comparedwith single internal
thoracic artery (SITA) grafting.2,3 With the use of
sophisticated risk adjustment in a group of 10,124 patients
from the Cleveland Clinic, Lytle and colleagues3 showed
that thosewho receivedBITAgrafting had a significantly de-
creased risk of death, reoperation, and angioplasty. Like-
wise, in a meta-analysis of more than 16,000 patients,
Rizzoli and colleagues7 demonstrated a survival advantage
of BITA over SITA use. More recently, a large retrospective
study fromGuru and colleagues6 suggested that there is both
a survival and morbidity benefit to MAG compared withgery c December 2012
Abbreviations and Acronyms
ACS ¼ acute coronary syndrome
BITA ¼ bilateral internal thoracic artery
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
COPD ¼ chronic obstructive pulmonary disease
CPB ¼ cardiopulmonary bypass
EF ¼ ejection fraction
HR ¼ hazard ratio
ITA ¼ internal thoracic artery
LITA ¼ left internal thoracic artery
MAG ¼ multiple arterial grafting
MHC ¼ Maritime Heart Center
MI ¼ myocardial infarction
PCI ¼ percutaneous coronary intervention
PHRU ¼ Population Health Research Unit
RITA ¼ right internal thoracic artery
SITA ¼ single internal thoracic artery
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Dsingle arterial grafts but not specifically BITA use.6 How-
ever, to date, there are only a few small randomized con-
trolled trials, with some suggesting a benefit to MAG.8-11
Work from our group was previously unable to show any
advantage of grafting strategies on survival in a series of
4696 patients undergoing CABG.12 The present study rep-
resents a fresh look at our initial population with the addi-
tion of several years of patients and follow-up to 10 years.
The goal of this study was to examine a larger population
of patients followed for a decade and determinewhich graft-
ing strategy would independently be associated with long-
term survival benefit after CABG.
MATERIALS AND METHODS
Patients
In this single-center retrospective cohort study, all patients who un-
derwent first-time isolated CABG at the Queen Elizabeth II Health Sci-
ences Center from 1995 to 2009 in Halifax, Canada, were identified
using the Maritime Heart Center (MHC) Cardiac Surgery Registry.
Patients were excluded if they underwent reoperative surgery, if they
received fewer than 2 grafts, or if arterial grafting did not include an
ITA.
Indications for CABG surgery were based on a weekly peer review pro-
cess, involving cardiologists, cardiac surgeons, and cardiac radiologists. In-
dividual patients were queued for surgery on the basis of objective criteria
as previously described.13,14 To facilitate links with administrative
longitudinal data, the study population was restricted to patients residing
in Nova Scotia at the time of surgery and eligible for provincial health
insurance coverage.
Operative Technique
A median sternotomy was performed in all patients. Off-pump surgery
was performed in standardized fashion as previously described.10 Briefly, 3
traction sutures were placed in the posterior pericardium for retractionThe Journal of Thoracic and Carfollowed by placement of a commercially available tissue stabilizer (Octo-
pus [Medtronic Inc, St Paul, Minn] and Corvasc [CoroNeo Inc, Montreal,
Canada]). A nontraumatic small bulldog clamp was then applied to the tar-
get vessel proximal to the anastomotic site to achieve hemostasis after ar-
teriotomy. All anastomoses were constructed with continuous suture
technique using 7-0 or 8-0 monofilament sutures.
CABG performed with cardiopulmonary bypass (CPB) was performed
in a standardized fashion using ascending aortic cannulation and 2-stage
venous cannulation of the right atrium. During CPB, mean arterial pressure
target was set at 60 mm Hg and body temperature was allowed to drift to
a minimum of approximately 32C. Intermittent cold blood cardioplegia
(1:4 blood to crystalloid with maximal Kþconcentration 22 meq/L) was de-
livered antegrade via the aortic root unless otherwise indicated.
In all cases, the choice of conduits or construction of grafts was based on
surgeon preferences rather than fixed criteria. Arterial conduits were har-
vested with minimal trauma (non-skeletonized internal thoracic artery)
and treated with a papaverine solution or nitroglycerine/calcium channel
blocker (verapamil) solution before use. Heparin was given at a dose of
300 to 400 IU/kg to achieve a target activated clotting time greater than
450 seconds in the CPB group compared with 200 IU/kg in the beating
heart group. On completion of anastomoses, both groups received prot-
amine sulfate to reverse the effects of heparin and return the activated clot-
ting time to preoperative levels. No special blood conservation techniques
were used other than non-hemic prime, retransfusion of all contents of the
oxygenator at the end of CPB, and acceptance of normovolemic anemia.
Postoperatively, non-hemic volume expanders were used routinely.
Postoperative Management
All patients received intravenous nitroglycerine infusions for the first 24
hours on return from the operating room unless hypotensive (systolic
blood pressure<90 mm Hg). Other routine postoperative medications in-
cluded daily aspirin and resumption of cholesterol-lowering agents, beta-
blockers, and angiotensin-converting enzyme inhibitors as appropriate.
Outcome Measures
The primary outcome was all-cause mortality (including perioperative
deaths) after CABG surgery. The secondary outcome was readmission to
hospital for acute coronary syndrome (ACS) (defined as any myocardial in-
farction [MI] or unstable angina) or repeat revascularization, as defined by
the International Classification of Diseases, 9th and 10th Revisions, Clin-
ical Modification. Risk-adjusted survival and risk-adjusted freedom from
hospital readmission for ACS were examined by Cox proportional hazards
modeling and presented as hazard ratios (HRs) with 95% confidence
interval (CI).
For the purpose of our primary analysis, patients were grouped accord-
ing to grafting strategies: 1) no arterial graft group, 2) SITA graft group,
and 3) BITA graft group.
In a secondary analysis, the SITA group was separated into SITAwith or
without additional arterial grafts in an effort to determine the role of MAG
versus BITA in providing a survival benefit post-CABG.
Data Sources
Data were obtained from established databases and the MHC Cardiac
Surgery Registry Database. Longitudinal data were obtained from the Pop-
ulation Health Research Unit (PHRU) at Dalhousie University. The MHC
database is a prospectively collected clinical database that collects pre-, in-
tra-, and postoperative information on all patients undergoing cardiac sur-
gery at the MHC. The MHC Registry data were linked to records in the
Canadian Institute for Health Information Discharge Abstract Database
and the Nova Scotia Vital Statistics database, housed by PHRU. The Cana-
dian Institute for Health Information Discharge Abstract Database enables
us to track all readmissions to hospital in Nova Scotia. The Nova Scotia
Vital Statistics database collects information on all deaths occurring within
the province of Nova Scotia.diovascular Surgery c Volume 144, Number 6 1409
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Preoperative variables of interest included age, gender, body mass index
(BMI), smoking history, diabetes, chronic obstructive pulmonary disease
(COPD), hypercholesterolemia, renal failure (serum creatinine > 176
mmol/L), hypertension, peripheral vascular disease, cerebrovascular disease,
left ventricular ejection fraction (EF<40% vs EF  40%), recent MI de-
fined as the occurrence of an MI in the 21 days before surgery, intra-aortic
balloon pump use, urgency of surgery (emergency for immediate operation,
urgent if needed to be performed within 24 hours, in-hospital urgent if the
patient was hospitalized before surgery, and elective or outpatient), prior
percutaneous coronary intervention (PCI), and number of diseased vessels
(triple-vessel or left main disease vs single- or double-vessel disease).
Intraoperative variables of interest included number of distal anastomo-
ses, sequential grafting, complete revascularization (defined as  1 grafts
to each significantly diseased territory), off-pump surgery, crossclamp
time, and total bypass time.
Statistical Analysis
The clinical characteristics of each grafting group (no ITA, SITA, BITA)
were examined univariately. Normally distributed continuous variableswere
reported as mean standard deviation and compared using analysis of var-
iance. Continuous variables thatwere not normally distributedwere reported
asmedian and interquartile range and compared by theKruskall–Wallis test.
Categoric variables were reported as frequencies and percentages, and ana-
lyzed by chi-square or Fisher exact test. Design variables were created for
reference level coding of categoric variables with more than 2 levels.
Univariate Cox proportional hazards analysis was performed to exam-
ine the prognostic value of each clinical characteristic on the primary
and secondary outcomes. Candidate variables for multivariate analysis
were selected on the basis of clinical relevance and the significance of uni-
variate associations with a P value less than .2.15 Multicollinearity was as-
sessed using linear regression analysis, where a variance inflation factor
greater than 4 indicated intercorrelation among variables. If multicollinear-
ity existed, correlated variables were combined into a single variable or
only 1 variable from a set of correlated variables was included in the
Cox proportional hazards model.
A non-parsimonious propensity score model was developed to calculate
the predicted probability of receiving BITAversus another grafting strategy
and included all variables deemed clinically relevant to conduit selection.
This approachwas used to limit bias that can arise because the effectiveness
of a treatment may be dependent on the reasons the treatment was chosen,
which in the present case was grafting strategy.
Quintiles of propensity score were used to adjust for potential selection
bias in the outcomes models. A non-parsimonious Cox proportional haz-
ards model was used to examine the relationship between grafting strategy
and time to death or time to first hospital readmission for ACS, adjusting for
all clinically relevant covariates regardless of P value. The assumption of
proportional hazards was assessed using the time-dependent covariate
test. For each covariate, interaction with time was expressed as
‘‘covariate3 log(time),’’ and this interaction term was tested in the model.
If the time interaction for a covariate was significant, that covariate was
modeled as time-dependent by including both the covariate and its time in-
teraction in the model. This approach allowed valid modeling of non-
proportional predictors.16
In a secondary analysis, SITA cases were separated into SITA with or
without additional arterial grafts, and a risk-adjusted Cox proportional
hazards model was used to determine the role of MAG versus BITA in pro-
viding a survival benefit post-CABG.
Adjusted survival curves were plotted using the corrected group progno-
sis method of Ghali and colleagues.17 All statistical analyses were per-
formed using SAS version 8.2 (SAS Institute Inc, Cary, NC). Although
this study included longitudinal data obtained from PHRU, the observa-
tions and opinions expressed are those of the authors and do not represent
those of PHRU.1410 The Journal of Thoracic and Cardiovascular SurEthics
This study was conducted with the full approval of the institutional
(Capital District Health Authority) Research Ethics Board. The require-
ment to obtain informed consent was waived under Section 2.1c of the
Tri-Council Policy Statement. All personal identifiers were stripped before
data analysis to ensure patient anonymity and confidentiality.RESULTS
A total of 8264 consecutive patients underwent first-time,
isolated CABG between 1995 and 2007. For the primary
analysis, patients were grouped on the basis of ITA use:
no ITA (8%), SITA (79%), or BITA (13%). Patient charac-
teristics are shown in Table 1. When compared with other
groups, patients receiving BITA grafts were younger;
more likely to be male; less likely to have renal failure, ce-
rebrovascular disease, low EF, or a recent MI; and less
likely to require a preoperative intra-aortic balloon pump.
Patients in the BITA group also underwent operation
more often on an elective basis when compared with pa-
tients receiving SITA or no ITA.
The proportion of patients in whom an SVG was used
was significantly different between groups, with only
36% of BITA, 89% of SITA, and 100% of no ITA cases
(Table 2). In the SITA groups, the majority of patients re-
ceived a LITA (99%), few received a RITA (1%), and
some received radial arteries (13%). Overall, there were
fewer distal anastomoses performed in the no ITA (2.9 
0.8 grafts) and SITA (3.2  0.9 grafts) groups compared
with the BITA group (3.2  1.0 grafts) (Table 1). Likewise,
patients in the BITA group were more likely to be com-
pletely revascularized, defined as 1 graft per significantly
diseased territory (88%), and required a significantly longer
clamp time to complete the procedure; in addition, a greater
proportion received all arterial grafts (65%). One should
note that RITA grafts were pedicled in 81% of patients
and used to graft the right coronary territory in 54%, cir-
cumflex territory in 25%, and left anterior descending
territory in 21%.
The overall unadjusted in-hospital mortality was 2.4%
for all patients undergoing CABG included in the study. Un-
adjusted in-hospital mortality was lowest in the BITA group
(1.7%; P<.0001) (Table 3). Likewise, unadjusted rates of
in-hospital permanent stroke were lowest in the BITA group
(0.7%, P<.0037, Table 3). However, the BITA group was
more likely to develop a deep sternal wound infection
(1.2%, P ¼ .014). The rate of deep sternal wound injection
in the diabetic patients in the BITA group was 2.54%
(7/276) compared with 0.75% (6/803) in nondiabetic pa-
tients (unadjusted outcomes). The unadjusted median
length of hospitalization was shortest for the BITA and
SITA groups compared with the no ITA group (P<.0001).
To minimize potential selection bias, a propensity score
model was developed to predict the probability of receiving
BITA and included the following variables: age, sex, BMI,gery c December 2012
TABLE 1. Comparison of preoperative characteristics among patients undergoing coronary bypass grafting
Variable No ITA n ¼ 631 (%) SITA n ¼ 6554 (%) BITA n ¼ 1079 (%) P value
Age, y 70.7  10.2 65.0  10.1 58.4  10.0 <.0001
Female sex 217 (34) 1612 (25) 194 (18) <.0001
BMI
<25 177 (28) 1325 (20) 191 (18) <.0001
25–29.9 266 (42) 2808 (43) 486 (45)
30–34.9 131 (21) 1669 (25) 304 (28)
35 57 (9) 752 (11) 98 (9)
Smoking history 434 (69) 4610 (70) 789 (73) .10
Diabetes 217 (34) 2449 (37) 276 (26) <.0001
Hypercholesterolemia 386 (61) 5257 (80) 894 (83) <.0001
Preoperative renal failure 81 (13) 332 (5) 19 (2) <.0001
Hypertension 431 (68) 4388 (67) 605 (56) <.0001
Peripheral vascular disease 160 (25) 1085 (17) 154 (14) <.0001
Cerebrovascular disease 107 (17) 879 (13) 101 (9) <.0001
EF<40 149 (24) 782 (12) 78 (7) <.0001
Recent MI<7 d 104 (16) 467 (7) 38 (4) <.0001
Preoperative IABP 114 (18) 465 (7) 34 (3) <.0001
CHF 167 (26) 903 (14) 69 (6) <.0001
COPD 146 (23) 919 (14) 115 (11) <.0001
Urgency of surgery
Elective 211 (33) 3208 (49) 661 (61) <.0001
IHU 185 (29) 2357 (36) 313 (29)
Urgent or emergency 235 (37) 989 (15) 105 (10)
Prior PCI 99 (16) 727 (11) 131 (12) .0022
Left-main/triple-vessel disease 471 (75) 5479 (84) 869 (81) <.0001
CHF, Congestive heart failure; IABP, intra-aortic balloon pump; IHU, in-hospital urgent (ie, waiting for surgery in-hospital>24 h).
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ripheral vascular disease, cardiovascular disease, COPD,
EF less than 40, congestive heart failure, recent MI less
than 7 days, prior PCI, urgency of surgery, left main/triple
vessel disease, and surgeon. The propensity score model
was well calibrated (Figure 1), and therewas adequate over-
lap of the distribution of propensity scores in the 2 groups.
Median propensity score with interquartile range was
0.352 (0.203–0.549) in the BITA group and 0.0369
(0.0114–0.111) in the non-BITA group. The receiver oper-
ating characteristic with 95% CI for the propensity score
model was 87.0% (86.2–88.3).TABLE 2. Intraoperative variables
Variable
No ITA
(%)
SITA
(%)
BITA
(%) P value
No. of grafts 3 (2–3) 3 (3–4) 3 (2–4) <.0001
SVG 100 89 36
LITA 0 99 100
RITA 0 1.1 100
RA 0 13 10
Gastroepiploic 0 0.2 0.7
TAG 0 11 65
LAD disease 80 95 94 <.0001
Complete revascularization 75 81 88 <.0001
Clamp time 57 (43–72) 64 (52–81) 72 (51–91) <.0001
LAD, Left anterior descending; RA, radial artery; SVG, saphenous vein graft; TAG,
total arterial grafting (all grafts as arteries).
The Journal of Thoracic and CarGiven the significant differences between groups, Cox
proportional hazards analysis was used to adjust for clinical
characteristics. Quintiles of propensity score were also in-
cluded in the models. None of the candidate variables for
multivariable modeling exceeded the threshold for multi-
collinearity. Over the entire follow-up period, 133 patients
(12%) died in the BITA group compared with 1434 patients
(22%) in the SITA group and 305 patients (48%) in the no
ITA group (P<.0001) (Table 3). After adjusting for clinical
covariates and propensity score in a model using SITA asTABLE 3. Unadjusted in-hospital and long-term outcomes after
coronary artery bypass grafting
Outcome No ITA (%) SITA (%) BITA(%) P value
In-hospital outcomes
Mortality 7.3 2.1 1.7 <.0001
Stroke 2.8 1.7 0.7 .0037
MI 1.1 1.1 0.4 .067
Deep sternal wound
infection
0 0.7 1.2 .014
Long-term outcomes
All-cause mortality 48.3 21.9 12.3 <.0001
Readmission for
ACS
23.9 18.1 15.8 .0001
Median follow-up
(IQR), y
3.5 (1.0–6.0) 4.6 (2.1–7.5) 5.4 (3.1–8.6) <.0001
IQR, Interquartile range.
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FIGURE 1. Calibration plot of observed versus predicted use of BITA
grafting in patients undergoing CABG. A non-parsimonious propensity
score model was developed to calculate the predicted probability of receiv-
ing BITA versus another grafting strategy and included all variables
deemed clinically relevant to conduit selection. Quintiles of propensity
score were used to adjust for potential selection bias in the outcomes
models. DF, Degrees of freedom; MSE, mean squared error.
FIGURE 3. Risk-adjusted freedom from admission to hospital for ACS
among no ITA, SITA, and BITA groups. BITA, Bilateral interal thoracic ar-
tery; CI, confidence interval; ITA, internal thoracic artery; SITA, single in-
ternal thoracic artery.
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independent predictor of long-term survival (HR, 0.818; CI,
0.672–0.996) and no ITA grafting as an independent predic-
tor of death after CABG (HR, 1.42; CI, 1.24–1.62). In other
terms, BITA grafting was shown to be associated with a sig-
nificant long-term survival benefit with risk-adjusted sur-
vival (Figure 2) and showed a 71.0% survival in patients
at 10 years compared with 65.9% for SITA and 57.6%
for no ITA. After discharge, 192 patients (17.8%) in the
BITA group were readmitted for cardiac reasons, defined
as ACS or repeat revascularization, compared with 1265 pa-
tients (19.3%) in the SITA group and 155 patients (24.6%)
in the no ITA group (P ¼ .002). This included 55 patients
(5.1%) in the BITA group, 334 patients (5.1%) in the
SITA group, and 30 patients (4.8%) in the no ITA group
who were readmitted for repeat revascularization in the
form of PCI or CABG surgery (P ¼ .93). Repeat CABGFIGURE 2. Risk-adjusted freedom from death among no ITA, SITA, and
BITA groups. BITA, Bilateral interal thoracic artery; CI, confidence inter-
val; ITA, internal thoracic artery; SITA, single internal thoracic artery.
1412 The Journal of Thoracic and Cardiovascular Surwas required in 1% of the patients in each group
(P ¼ .60). Given that the rates of repeat revascularization
were no different between groups, we looked at freedom
from readmission to hospital for ACS, defined as any MI
or unstable angina (Figure 3). After adjusting for clinical
covariates, BITA grafting was associated with a signifi-
cantly better freedom from readmission to hospital for
ACS when compared with SITA or no ITA (P¼ .018), sug-
gesting that a mechanism for the improved survival ob-
served in patients with BITA grafting may be protection
against later myocardial ischemic events.
The following variables were also found to be indepen-
dent predictors of mortality: increased age (60 years),
COPD, female gender, diabetes, preoperative renal failure,
peripheral vascular disease, low EF (<40%), extremes of
weight (low and high BMI), non-elective surgery, failure
to receive an ITA graft, and incomplete revascularization
(Table 4).
Given that a number of patients in the SITA group also
received additional arterial grafts, we performed a separate
analysis to determine whether MAG (other than BITA) was
associated with a survival benefit. In this additional analy-
sis, patients with MAG were defined as patients with
SITA in whom 1 or more additional arterial grafts (not
SVG) were used without using BITA. In this Cox propor-
tional hazards analysis, patients were separated into 4
groups: no ITA, SITA (only saphenous vein graft), SITA
(þother arterial grafts), and BITA. With this approach, there
was no apparent survival benefit to receiving additional ar-
terial grafts to a LITA if this arterial graft was not the RITA
(Figure 4). After adjusting for covariates, BITA grafting re-
mained associated with a survival benefit when compared
with all other forms of grafting.
DISCUSSION
In this large prospective registry (8264 patients) includ-
ing all consecutive patients who underwent CABG, wegery c December 2012
TABLE 4. Non-parsimonious Cox proportional hazards model for
survival
Variable Adjusted HR 95% CI
No ITA 1.42 1.24–1.62
SITA 1.00
BITA 0.818 0.672–0.996
Incomplete revascularization 1.23 1.10–1.38
Age<60 y 1.00
Age 60–69 y 1.75 1.49–2.06
Age 70–79 y 2.96 2.52–3.48
Age 80þy 4.86 3.96–5.98
BMI<25 1.20 1.07–1.34
BMI 25–29.9 1.00
BMI 30–34.9 1.00 0.89–1.13
BMI>35 1.22 1.04–1.43
Diabetes 1.50 1.35–1.66
RF 2.05 1.78–2.36
PVD 1.69 1.52–1.88
COPD 1.66 1.48–1.85
EF<40 1.80 1.60–2.02
Elective 1.00
IHU 1.34 1.19–1.52
Urgent 1.78 1.54–2.05
Emergency 1.83 1.48–2.26
Propensity score quintiles
Q1 lowest 1.00
Q2 2nd lowest 0.943 0.822–1.08
Q3 middle 0.848 0.729–0.987
Q4 2nd highest 0.891 0.767–1.04
Q5 highest 0.853 0.699–1.04
IHU, In-hospital urgent (ie, waiting for surgery in-hospital>24 h); PVD, peripheral
vascular disease; RF, renal failure (creatinine>176 mmol/L). The model was also
adjusted for female sex, cardiovascular disease, off-pump surgery, sequential graft-
ing, and interactions with log(time) for the time-dependent covariates age, diabetes,
EF<40, and urgency of surgery.
FIGURE 4. Risk-adjusted freedom from death among no ITA, SITA
(without additional arterial grafts), SITA (with additional arterial grafts),
and BITA groups. BITA, Bilateral interal thoracic artery; CI, confidence in-
terval; ITA, internal thoracic artery;MAG, multiple arterial grafting; SITA,
single internal thoracic artery; SVG, saphenous vein graft.
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ical differences between CABG groups. The methods used
included Cox modeling, which considers time as a variable,
and the propensity score, which is used to account for poten-
tial bias that arises in allocating a particular treatment, that
is, grafting strategy. After adjusting for differences between
groups, we showed that ITA grafting provides an incremen-
tal survival benefit. This means that patients not receiving
an ITA graft were more likely to die during follow-up
(HR, 1.42; CI, 1.24–1.62). Conversely, patients who re-
ceived BITA grafts were found to have a survival advantage
(HR, 0.818; CI, 0.672–0.996) when compared with what is
often referred to as the standard of care: SITA to the left an-
terior descending artery. Our findings are in keeping with
published work from other investigators who have sug-
gested a survival advantage to the use of BITA grafts.2,18
What is novel about our analysis is that we showed that
MAG without BITAs was not associated with a survival
advantage, with survival similar to that for SITA grafting.
Our findings suggest that the survival benefit of MAG
proposed by some investigators may have been driven byThe Journal of Thoracic and Carthe benefit offered by BITA rather than other non-BITA ar-
terial grafts.6 Our findings explain our inability to show
a survival benefit in patients receiving MAG in a previous
study using half this population and shorter follow-up,
and not stratified to BITA grafts.12 We provide convincing
evidence that BITA grafts are associated with an optimal
long-term survival advantage (>10 years) when compared
with other forms of grafting. Furthermore, our findings sug-
gest that the separation of the survival curves appears to
continue over time, such that this survival advantage will
likely persist and become more important in the future.
In a retrospective study such as this, it is difficult to pro-
vide a clear mechanism by which BITA grafts are associ-
ated with a survival benefit.2,18,19 However, we showed
that patients receiving BITA grafts had a significantly
better freedom from readmission to hospital with an ACS.
This observation is important because it provides
a mechanism by which BITA may be associated with
a survival advantage over conventional saphenous vein
grafting by protecting against recurrent ischemic events.
Although some have suggested that the benefit of BITA
grafting is related to improved freedom from ACS or
acute MI, their findings have not been consistent.20,21
Although it would be tempting to speculate that the
mechanism responsible for less ischemic events in
patients receiving BITA grafts would be related to better
graft patency, we cannot make that claim. Given that no
systematic angiographic follow-up was performed in the
present study, we were unable to conclusively link graft pa-
tency to improved freedom from ACS or survival.
In the present analysis, it was not possible to explore the
exact reason why patients received a particular grafting
strategy because this was left to the discretion of the sur-
geon. This may be particularly evident for the no ITA group,
which included 631 patients (8% of all patients). Of note,
patients in this group were older (18% octogenarians),diovascular Surgery c Volume 144, Number 6 1413
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descending disease. Furthermore, this study spanned ap-
proximately 2 decades with evolving notions on the use of
ITA grafts for all patients. Additional reasons for not using
any ITA graft would include injury to the conduit at the time
of harvest, because Queen Elizabeth II Health Sciences
Center is a teaching hospital, and poor quality of the con-
duit, which could not be assessed in the analysis.
Mediastinitis (or deep sternal wound infection) is an in-
frequent complication reported in 1.2% of BITA cases in
our study, yet a potentially devastating complication after
CABG, which is associated with increased cost of care, pro-
longed hospitalization, and increased morbidity and mortal-
ity.22 This in part explains some of the reluctance of certain
surgeons in using BITA grafts in all patients. Unadjusted
univariate rates of deep sternal wound infection were signif-
icantly higher in patients with BITA, and given that patients
with BITA were generally healthier, this suggests that this
observation is likely real. We could not assess the benefit
of skeletonized ITA grafts in the present study despite grow-
ing evidence of a potential benefit in reducing the risk of
mediastinitis.23,24 To date, the use of ITA skeletonization
has not become standard practice at Queen Elizabeth II
Health Sciences Center.
We have provided evidence to suggest that certain graft-
ing strategies, particularly BITA grafts, offer a survival ad-
vantage to patients undergoing CABG. However, despite
this apparent benefit of a particular grafting strategy, there
seems to be huge variability among centers, with the overall
proportion of CABG surgeries in which BITA are used.6,25
We reported a BITA use of 13% andMAG use of 24% in all
patients presenting for CABG surgery at Queen Elizabeth II
Health Sciences Center over a 17-year period. Although this
proportion is not high, it is well above what is normally re-
ported by the published Society of Thoracic Surgeons’ da-
tabase, with a 5% use of BITAs (available at: http://
wwwstsorg/documents). Given our findings that BITA use
would result in better long term-survival, one could specu-
late that CABG results may continue to show improvement
in the long-term, but only if more surgeons significantly in-
crease their use of BITA grafts.
We did not explorewhy BITA grafting seems to be under-
used by many surgeons. One can easily speculate that the
lack of obvious benefit of this approach early after CABG
in comparison with the perceived risks likely contributes.
The theoretic benefit of MAG relies heavily on proposed
improved long-term patency, which is not associated with
an immediate feedback to treating surgeons. This also ex-
plains why it has been difficult to obtain conclusive results
demonstrating the superiority of one surgical approach
when more than 5 to 10 years are needed to begin to see
the clinical benefit. This is particularly true when one is
faced with the excellent long-term survival of patients un-
dergoing CABG, as illustrated from results from this1414 The Journal of Thoracic and Cardiovascular Surregistry and many others.18,19 Finally, although our
findings are in keeping with some published literature,
one should keep in mind that statistical modeling could
not fully adjust for all potentially relevant variables that
make a surgeon select a particular patient for BITA
grafting. This is best illustrated by the fact that in the
absence of conduit problems such as varicose veins, BITA
tends to be offered to younger, healthier, less urgent
patients who often are expected to do well. In an effort to
adjust for this potential bias, we included surgeon in the
propensity score model and subsequently used propensity
score in the outcomes models.CONCLUSIONS
With the use of statistical modeling and risk adjustment,
we showed that MAG using BITAs offered a long-term sur-
vival advantage over all other forms of grafting.References
1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ,
et al. Percutaneous coronary intervention versus coronary-artery bypass grafting
for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
2. Taggart DP, D’Amico R, Altman DG. Effect of arterial revascularisation on sur-
vival: a systematic review of studies comparing bilateral and single internal
mammary arteries. Lancet. 2001;358:870-5.
3. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R,
et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc
Surg. 1999;117:855-72.
4. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW,
et al. Influence of the internal-mammary-artery graft on 10-year survival and
other cardiac events. N Engl J Med. 1986;314:1-6.
5. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with
internal-thoracic-artery grafts–effects on survival over a 15-year period. N
Engl J Med. 1996;334:216-9.
6. Guru V, Fremes SE, Tu JV. How many arterial grafts are enough? A population-
based study of midterm outcomes. J Thorac Cardiovasc Surg. 2006;131:
1021-8.
7. Rizzoli G, Schiavon L, Bellini P. Does the use of bilateral internal mammary ar-
tery (IMA) grafts provide incremental benefit relative to the use of a single IMA
graft? A meta-analysis approach. Eur J Cardiothorac Surg. 2002;22:781-6.
8. Muneretto C, Bisleri G, Negri A, Manfredi J, Carone E, Morgan JA, et al. Left
internal thoracic artery-radial artery composite grafts as the technique of choice
for myocardial revascularization in elderly patients: a prospective randomized
evaluation. J Thorac Cardiovasc Surg. 2004;127:179-84.
9. Muneretto C, Bisleri G, Negri A, Manfredi J, Metra M, Nodari S, et al. Total ar-
terial myocardial revascularization with composite grafts improves results of cor-
onary surgery in elderly: a prospective randomized comparison with
conventional coronary artery bypass surgery. Circulation. 2003;108(Suppl 1):
II29-33.
10. Muneretto C, Negri A, Manfredi J, Terrini A, Rodella G, Elqarra S, et al. Safety
and usefulness of composite grafts for total arterial myocardial revascularization:
a prospective randomized evaluation. J Thorac Cardiovasc Surg. 2003;125:
826-35.
11. Damgaard S,Wetterslev J, Lund JT, Lilleor NB, PerkoMJ, Kelbaek H, et al. One-
year results of total arterial revascularization vs. conventional coronary surgery:
CARRPO trial. Eur Heart J. 2009;30:1005-11.
12. Legare JF, Hassan A, Buth KJ, Sullivan JA. The effect of total arterial grafting on
medium-term outcomes following coronary artery bypass grafting. J Cardio-
thorac Surg. 2007;2:44.
13. Legare JF, MacLean A, Buth KJ, Sullivan JA. Assessing the risk of waiting for
coronary artery bypass graft surgery among patients with stenosis of the left
main coronary artery. CMAJ. 2005;173:371-5.
14. Ray AA, Buth KJ, Sullivan JA, Johnstone DE, Hirsch GM. Waiting for cardiac
surgery: results of a risk-stratified queuing process. Circulation. 2001;104:
I92-8.gery c December 2012
Kelly et al Acquired Cardiovascular Disease15. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen
risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49:907-16.
16. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part III: multi-
variate data analysis—choosing a model and assessing its adequacy and fit. Br
J Cancer. 2003;89:605-11.
17. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD, et al. Compar-
ison of 2 methods for calculating adjusted survival curves from proportional haz-
ards models. JAMA. 2001;286:1494-7.
18. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. The
effect of bilateral internal thoracic artery grafting on survival during 20 postop-
erative years. Ann Thorac Surg. 2004;78:2005-14.
19. Stevens LM, Carrier M, Perrault LP, Hebert Y, Cartier R, Bouchard D, et al. Sin-
gle versus bilateral internal thoracic artery grafts with concomitant saphenous
vein grafts for multivessel coronary artery bypass grafting: effects on mortality
and event-free survival. J Thorac Cardiovasc Surg. 2004;127:1408-15.
20. Berreklouw E, Rademakers PP, Koster JM, van Leur L, van der Wielen BJ,
Westers P. Better ischemic event-free survival after two internal thoracic artery
grafts: 13 years of follow-up. Ann Thorac Surg. 2001;72:1535-41.The Journal of Thoracic and Car21. Dewar LR, Jamieson WR, Janusz MT, Adeli-Sardo M, Germann E, MacNab JS,
et al. Unilateral versus bilateral internal mammary revascularization. Survival
and event-free performance. Circulation. 1995;92:II8-13.
22. Toumpoulis IK, Anagnostopoulos CE, Derose JJ Jr, Swistel DG. The impact of
deep sternal wound infection on long-term survival after coronary artery bypass
grafting. Chest. 2005;127:464-71.
23. Lev-Ran O, Braunstein R, Nesher N, Ben-Gal Y, Bolotin G, Uretzky G. Bilat-
eral versus single internal thoracic artery grafting in oral-treated diabetic sub-
sets: comparative seven-year outcome analysis. Ann Thorac Surg. 2004;77:
2039-45.
24. Boodhwani M, Lam BK, Nathan HJ, Mesana TG, Ruel M, Zeng W, et al.
Skeletonized internal thoracic artery harvest reduces pain and dysesthesia
and improves sternal perfusion after coronary artery bypass surgery: a ran-
domized, double-blind, within-patient comparison. Circulation. 2006;114:
766-73.
25. Baskett RJ, Cafferty FH, Powell SJ, Kinsman R, Keogh BE, Nashef SA. Total ar-
terial revascularization is safe: multicenter ten-year analysis of 71,470 coronary
procedures. Ann Thorac Surg. 2006;81:1243-8.diovascular Surgery c Volume 144, Number 6 1415
A
C
D
